Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage-Reference-Cited by-同舟云学术

Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage

Published:2009-02 Issue:2 Volume:11 Page:264-273
ISSN:1286-4579
Container-title:Microbes and Infection
language:en
Short-container-title:Microbes and Infection

Author:

Medeiros Gabriela A.,Silvério Jaline C.,Marino Ana Paula M.P.,Roffê Ester,Vieira Valeska,Kroll-Palhares Karina,Carvalho Cristiano E.,Silva Andréa Alice,Teixeira Mauro M.,Lannes-Vieira Joseli

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Microbiology

Reference33 articles.

1. Chagas disease: what is known and what is needed – a background article;Coura;Mem. Inst. Oswaldo Cruz.,2007

2. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease;Freitas;Int. J. Cardiol,2005

3. Where do we stand on the autoimmunity hypothesis of Chagas disease?;Kierszenbaum;Trends Parasitol.,2005

4. Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis;Marino;Circulation,2004

5. Chemokines, inflammation and Trypanosoma cruzi infection;Teixeira;Trends Immunol.,2002

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inclusion body myositis, viral infections, and TDP-43: a narrative review;Clinical and Experimental Medicine;2024-05-02

2. Theracurmin Modulates Cardiac Inflammation in Experimental Model of Trypanosoma cruzi Infection;Tropical Medicine and Infectious Disease;2023-06-28

3. Insights from the use of erythropoietin in experimental Chagas disease;International Journal for Parasitology: Drugs and Drug Resistance;2022-08

4. T-Cell Subpopulations Exhibit Distinct Recruitment Potential, Immunoregulatory Profile and Functional Characteristics in Chagas versus Idiopathic Dilated Cardiomyopathies;Frontiers in Cardiovascular Medicine;2022-02-02

5. Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach*;Memórias do Instituto Oswaldo Cruz;2022